Related Experiment Video

Updated: May 31, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

ERK2 is essential for the growth of human epithelioid malignant mesotheliomas

Arti Shukla1, Jedd M Hillegass, Maximilian B MacPherson

  • 1Department of Pathology, University of Vermont College of Medicine, Burlington, VT 05405-0068, USA. arti.shukla@uvm.edu

International Journal of Cancer
|June 29, 2011
PubMed

Insights

Extracellular signal-regulated kinase 2 (ERK2) is crucial for the growth and spread of malignant mesothelioma (MM) tumors. Inhibiting ERK2 significantly reduced tumor development and key cancer-related gene expression in preclinical models.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Extracellular signal-regulated kinases (ERK) are implicated in cell injury, repair, differentiation, and carcinogenesis.
  • Malignant mesothelioma (MM) is an asbestos-induced cancer with a poor prognosis, necessitating research into its underlying molecular mechanisms.

Purpose of the Study:

  • To investigate the specific roles of ERK1 and ERK2 in the development and progression of human epithelioid malignant mesothelioma.
  • To identify key molecular targets regulated by ERK2 in MM.

Main Methods:

  • Utilized a MEK1/2 inhibitor (U0126) and RNA silencing (shERK1, shERK2) to modulate ERK activity in MM cell lines.
  • Assessed tumor growth in severe combined immunodeficiency (SCID) mice xenograft models.
  • Performed microarray and quantitative real-time PCR to analyze gene expression changes.

Main Results:

  • ERK2, but not ERK1, was critical for MM cell transformation and homeostasis.
  • Silencing ERK2 significantly attenuated tumor growth, migration, invasion, and colony formation in vitro and in vivo.
  • ERK2 inhibition led to significant alterations in the expression of genes including CASP1, TRAF1, FAS, SEMA3E, and BCL2L1.
  • Decreased Semaphorin 3E (SEMA3E) mRNA levels were observed, suggesting a role in angiogenesis inhibition.

Conclusions:

  • ERK2 plays a pivotal role in the pathogenesis of epithelioid malignant mesothelioma through regulation of critical gene expression.
  • Targeting ERK2 presents a potential therapeutic strategy for MM.
  • ERK signaling may have heterogeneous effects across different MM subtypes.

More Related Videos

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...